Lyell Immunopharma
The Principal, Quality Assurance at Lyell will provide quality oversight and leadership across the product lifecycle for cell therapy products, partnering with manufacturing, process development, and regulatory teams. The role ensures compliance with GMP requirements, supports process validation, technology transfer, and regulatory submissions, and drives continuous improvement and inspection readiness.
Headquarters
South San Francisco, California, United States
Company Size
201-500 employees
Founded
2018
Lyell is a fully integrated biopharmaceutical company developing next‑generation T‑cell reprogramming technologies to create durable CAR T‑cell therapies for hematologic malignancies and solid tumors. Their platform-driven approach spans discovery through clinical development, with active programs and trials such as the PiNACLE study for aggressive B‑cell non‑Hodgkin lymphoma and the recently acquired GCC‑targeted candidate LYL273. Lyell is patient‑focused, aiming to improve outcomes for cancers with significant unmet medical need.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Lyell Immunopharma.
7% below the average for this role
HC Wainwright & Co. Maintains Lyell Immunopharma (LYEL) Neutral Recommendation
5 days ago
Associate Director, Quality Assurance (Operations)
Miltenyi Biotec
Executive Director, GMP Quality Assurance
Artiva Biotherapeutics
Senior Quality Engineer
Verista, Inc.
Associate Director, Quality Assurance (GMP QC Lab Oversight)
Coherus Oncology
Senior Manager, GMP Quality
Revolution Medicines
Quality Assurance Lead
AstraZeneca